Company Information

CIN
Status
Date of Incorporation
22 March 2007
State / ROC
Vijayawada / ROC Vijayawada
Last Balance Sheet
31 March 2023
Last Annual Meeting
22 September 2023
Paid Up Capital
2,708,324,330
Authorised Capital
3,180,000,000

Directors

Girish Dixit
Girish Dixit
Director/Designated Partner
almost 2 years ago
Sanjit Singh Lamba
Sanjit Singh Lamba
Managing Director
over 15 years ago

Past Directors

Mitsuru Shomon
Mitsuru Shomon
Additional Director
about 4 years ago
Kazuhiko Tamura
Kazuhiko Tamura
Additional Director
over 4 years ago
Hideshi Yamamoto
Hideshi Yamamoto
Additional Director
over 4 years ago
Susumu Kimura
Susumu Kimura
Additional Director
over 5 years ago
Shohei Kanazawa
Shohei Kanazawa
Additional Director
over 5 years ago
Tetsuya Oishi
Tetsuya Oishi
Director
almost 6 years ago
Sayoko Sasaki .
Sayoko Sasaki .
Additional Director
about 8 years ago
Yoshiteru Kato .
Yoshiteru Kato .
Additional Director
about 8 years ago
Katsuya Tagami .
Katsuya Tagami .
Additional Director
about 8 years ago
Hideshi Honda
Hideshi Honda
Additional Director
over 9 years ago
Asatani Junichi
Asatani Junichi
Additional Director
over 9 years ago
Hidehiro Miyake
Hidehiro Miyake
Additional Director
over 9 years ago
Toshihiko Naito
Toshihiko Naito
Director
about 15 years ago
Takafumi Asano
Takafumi Asano
Director
about 15 years ago
Takeshi Ogoshi
Takeshi Ogoshi
Additional Director
over 17 years ago
Hisamaro Garugu
Hisamaro Garugu
Nominee Director
over 18 years ago

Patents

Fused 1,3 Dihydro Imidazole Ring Compounds

The objective of this invention is to provide novel compounds that show excellent DPPIV-inhibiting activity. The present invention provides compounds represented by the general formula (I), salts thereof, or hydrates thereof, (i) [wherein, T1 stands for a monocyclic or bicyclic 4 to 12-membered heterocycle havi...

Process For The Preparation Of Bazedoxifene Acetate Polymorphic Form A

The present application provides processes for the preparation of polymorphic form A of Bazedoxifene acetate. The present application also provides an industrially viable process for the preparation of Bazedoxifene acetate polymorphic form A.

"Process For The Preparation Of Bazedoxifene Acetate

The  present  application  provides  processes  for  the  preparation  of Bazedoxifene acetate polymorphic form A. The present application also provides an industrially viable process for the preparation of Bazedoxifene acetate polymorphic form A.

Registered Trademarks

Quicobal Eisai Pharmaceuticals India

[Class : 5] Pharmaceutical Preparations

Almigra Eisai Pharmaceuticals India

[Class : 5] Pharmaceutical Preparations.

Ezegalin Sr Eisai Pharmaceuticals India

[Class : 5] Pharmaceutical Preparations.
View +15 more Brands for Eisai Pharmaceuticals India Private Limited.

Documents

Form MSME FORM I-04042021_signed
Form MGT-7-04042021_signed
Form MSME FORM I-24122020_signed
Form MGT-14-09122020-signed
Optional Attachment-(3)-04122020
Optional Attachment-(1)-04122020
Optional Attachment-(4)-04122020
Altered articles of association-04122020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-04122020
Optional Attachment-(2)-04122020
Approval letter for extension of AGM;-19112020
Copy of MGT-8-19112020
List of share holders, debenture holders;-19112020
Form DPT-3-13112020_signed
Approval letter of extension of financial year of AGM-05112020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-05112020
Form AOC-4(XBRL)-05112020_signed
Form MSME FORM I-28102020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-22102020
Optional Attachment-(1)-22102020
Altered articles of association-22102020
Notice of resignation;-13102020
Form DIR-12-13102020_signed
Evidence of cessation;-13102020
Optional Attachment-(1)-13102020
Form DPT-3-26072020-signed
Form DIR-12-04072020_signed
Optional Attachment-(4)-04072020
Optional Attachment-(3)-04072020
Notice of resignation;-04072020